Primary Cilia Are Lost in Preinvasive and Invasive Prostate Cancer

Hassounah, Nadia B.; Nagle, Ray; Saboda, Kathylynn; Roe, Denise J.; Dalkin, Bruce L.; McDermott, Kimberly M.
July 2013
PLoS ONE;Jul2013, Vol. 8 Issue 7, p1
Academic Journal
Prostate cancer is the second most commonly diagnosed cancer in men worldwide. Little is known about the role of primary cilia in preinvasive and invasive prostate cancer. However, reduced cilia expression has been observed in human cancers including pancreatic cancer, renal cell carcinoma, breast cancer, cholangiocarcinoma, and melanoma. The aim of this study was to characterize primary cilia expression in preinvasive and invasive human prostate cancer, and to investigate the correlation between primary cilia and the Wnt signaling pathway. Human prostate tissues representative of stages of prostate cancer formation (normal prostate, prostatic intraepithelial neoplasia (PIN), and invasive prostate cancer (including perineural invasion)) were stained for ciliary proteins. The frequency of primary cilia was determined. A decrease in the percentage of ciliated cells in PIN, invasive cancer and perineural invasion lesions was observed when compared to normal. Cilia lengths were also measured to indirectly test functionality. Cilia were shorter in PIN, cancer, and perineural invasion lesions, suggesting dysfunction. Primary cilia have been shown to suppress the Wnt pathway. Increased Wnt signaling has been implicated in prostate cancer. Therefore, we investigated a correlation between loss of primary cilia and increased Wnt signaling in normal prostate and in preinvasive and invasive prostate cancer. To investigate Wnt signaling in our cohort, serial tissue sections were stained for β-catenin as a measure of Wnt signaling. Nuclear β-catenin was analyzed and Wnt signaling was found to be higher in un-ciliated cells in the normal prostate, PIN, a subset of invasive cancers, and perineural invasion. Our results suggest that cilia normally function to suppress the Wnt signaling pathway in epithelial cells and that cilia loss may play a role in increased Wnt signaling in some prostate cancers. These results suggest that cilia are dysfunctional in human prostate cancer, and increase Wnt signaling occurs in a subset of cancers.


Related Articles

  • Decreased expression of mucin 18 is associated with unfavorable postoperative prognosis in patients with clear cell renal cell carcinoma. Qi Bai; Li Liu; Qilai Long; Yu Xia; Jiajun Wang; Jiejie Xu; Jianming Guo // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 9, p11005 

    Background: MUC18 is correlated with tumor progression and metastasis in types of malignancy. But the role of MUC18 in clear cell renal cell carcinoma remains unclear. In this study, we aimed to investigate the expression of MUC18 and its correlation with clinical outcomes in clear cell renal...

  • Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis. Fuessel, Susanne; Erdmann, Kati; Taubert, Helge; Lohse-Fischer, Andrea; Zastrow, Stefan; Meinhardt, Matthias; Bluemke, Karen; Hofbauer, Lorenz; Fornara, Paolo; Wullich, Bernd; Baretton, Gustavo; Magdolen, Viktor; Wirth, Manfred P.; Kotzsch, Matthias // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    Background Members of the urokinase-type plasminogen activator (uPA) system including uPA, its receptor uPAR and the plasminogen activator inhibitor 1 (PAI-1) play an important role in tumour invasion and progression in a variety of tumour types. Since the majority of clear cell renal cell...

  • Expression of Dicer and Its Related MiRNAs in the Progression of Prostate Cancer. Bian, Xiaojie; Shen, Yijun; Zhang, Guiming; Gu, Chenyuan; Cai, Ying; Wang, Chaofu; Zhu, Yiping; Zhu, Yao; Zhang, Hailiang; Dai, Bo; Ye, Dingwei // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Dicer is aberrantly expressed in several types of malignancies. Cleaved by Dicer, the small noncoding microRNAs (miRNAs) are considered potential tools for the diagnosis and prognosis of cancer. This study investigated the expression of miRNAs thought to target Dicer. Expression of 1,205 human...

  • Deregulation of MiR-34b/Sox2 Predicts Prostate Cancer Progression. Forno, Irene; Ferrero, Stefano; Russo, Maria Veronica; Gazzano, Giacomo; Giangiobbe, Sara; Montanari, Emanuele; Del Nero, Alberto; Rocco, Bernardo; Albo, Giancarlo; Languino, Lucia R.; Altieri, Dario C.; Vaira, Valentina; Bosari, Silvano // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Most men diagnosed with prostate cancer will have an indolent and curable disease, whereas approximately 15% of these patients will rapidly progress to a castrate-resistant and metastatic stage with high morbidity and mortality. Therefore, the identification of molecular signature(s) that detect...

  • Cutaneous Metastases in Renal Cell Carcinoma. Bujons, A.; Pascual, X.; Martínez, R.; Rodríguez, O.; Palou, J.; Villavicencio, H. // Urologia Internationalis;Jan2008, Vol. 80 Issue 1, p111 

    Cutaneous metastases from a renal cell carcinoma are rarely diagnosed during life. We report a case of renal carcinoma metastatic to the skin that occurred 18 months after kidney removal. The cutaneous metastasis was excised. Cutaneous metastases from urological tumors are uncommon and occur in...

  • Collecting Duct Renal Cell Carcinoma: Two Different Clinical Stages, Two Different Clinical Outcomes. Vá;zquez-Lavista, L. G.; Uribe-Uribe, N.; Gabilondo-Navarro, F. // Urologia Internationalis;Jul2008, Vol. 81 Issue 1, p116 

    Collecting duct carcinoma (CDC) of Bellini is a rare variant of renal cell carcinoma. It tends to be more aggressive when locally advanced or when having distant spread on diagnosis. The only favorable prognosis factor is low-stage, low-grade, with disease-free survival reported up to 5 years....

  • RCDB: Renal Cancer Gene Database. Ramana, Jayashree // BMC Research Notes;2012, Vol. 5 Issue 1, p246 

    Background: Renal cell carcinoma or RCC is one of the common and most lethal urological cancers, with 40% of the patients succumbing to death because of metastatic progression of the disease. Treatment of metastatic RCC remains highly challenging because of its resistance to chemotherapy as well...

  • Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma. Tantravahi, Srinivas K.; Albertson, Daniel; Agarwal, Archana M.; Ravulapati, Sowmya; Poole, Austin; Patel, Shiven B.; Hawatmeh, Jamil S.; Straubhar, Alli M.; Liu, Ting; Stenehjem, David D.; Agarwal, Neeraj // Journal of Oncology;1/20/2015, Vol. 2015, p1 

    Metastatic renal cell carcinoma with sarcomatoid histology (SmRCC) is associated with poor survival. No data is available from randomized trials on the efficacy of vascular endothelial growth factor (VEGF) and mammalian target of rapamycin (mTOR) inhibitors in SmRCC. We identified SmRCC patients...

  • Identification of pVHL as a Novel Substrate for Aurora-A in Clear Cell Renal Cell Carcinoma (ccRCC). Martin, Benedicte; Chesnel, Franck; Delcros, Jean-Guy; Jouan, Florence; Couturier, Anne; Dugay, Frederic; Le Goff, Xavier; Patard, Jean-Jacques; Fergelot, Patricia; Vigneau, Cecile; Rioux-Leclerq, Nathalie; Arlot-Bonnemains, Yannick // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Clear cell renal cell carcinoma (ccRCC) is the most common histological subtype of kidney cancer and is often characterized by mutations or deletions of the Von Hippel Lindau (VHL) tumour suppressor gene. Aurora gene family members are implicated in proper mitotic progression and spindle...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics